(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial (Q30581273)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | (90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial |
scientific article |
Statements
1 reference
(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial (English)
1 reference
Christian W Scholz
1 reference
Antonello Pinto
1 reference
Werner Linkesch
1 reference
Ola Lindén
1 reference
Andreas Viardot
1 reference
Ulrich Keller
1 reference
Georg Hess
1 reference
Kristina Lerch
1 reference
Ferdinando Frigeri
1 reference
Manuela Arcamone
1 reference
Andrea Stroux
1 reference
Bernd Frericks
1 reference
Christiane Pott
1 reference
Antonio Pezzutto
1 reference
10 December 2012
1 reference
1 reference
31
1 reference
308-313
1 reference
Identifiers
1 reference
1 reference